PRF Technologies (PRFX) Cash & Current Investments (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Cash & Current Investments of $4.1 million in Q4 2025, up 19.03% on a QoQ basis from $3.5 million in Q2 2025, and down 2.82% year-over-year from $4.3 million in Q4 2024.
PRF Technologies (PRFX) Cash & Current Investments (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Cash & Current Investments across 7 years of filings, most recently posting $4.1 million for Q4 2025.
- Quarterly Cash & Current Investments fell 2.82% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (down 2.82% YoY) and the FY2025 annual result came in at $4.1 million, down 2.82% from the prior year.
- Cash & Current Investments improved to $4.1 million in Q4 2025, from $3.5 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $19.4 million in Q1 2021 and troughed at $10000.0 in Q4 2023.
- A 5-year average of $9.8 million and a median of $8.6 million in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 99.9% — and 2024, when it soared 42510.0%.
- Tracing PRFX's Cash & Current Investments over 5 years: stood at $16.5 million in 2021, then plunged by 38.44% to $10.2 million in 2022, then sank by 99.9% to $10000.0 in 2023, then surged by 42510.0% to $4.3 million in 2024, then retreated by 2.82% to $4.1 million in 2025.
- Business Quant data shows PRFX's Cash & Current Investments at $4.1 million in Q4 2025, $3.5 million in Q2 2025, and $4.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | PRF Technologies | 984,918.95 | -2.41 Mn | - | 4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.14 Mn |
| Jun 30, 2025 | 3.48 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 8.59 Mn |
| Jun 30, 2023 | 6.15 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 10.18 Mn |
| Sep 30, 2022 | 12.96 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 15.42 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.79 Mn |
| Mar 31, 2021 | 19.42 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Sep 30, 2020 | 17.72 Mn |
| Jun 30, 2020 | 544,000.00 |